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A biotechnology-derived corn variety, MON 87411, containing a suppression cassette that expresses an
inverted repeat sequence that matches the sequence of western corn rootworm (WCR; Diabrotica vir-
gifera virgifera) has been developed. The expression of the cassette results in the formation of a double-
stranded RNA (dsRNA) transcript containing a 240 bp fragment of the WCR Snf7 gene (DvSnf7) that
confers resistance to corn rootworm by suppressing levels of DvSnf7 mRNA in WCR after root feeding.
Internationally accepted guidelines for the assessment of genetically modiﬁed crop products have been
developed to ensure that these plants are as safe for food, feed, and environmental release as their non-
modiﬁed counterparts (Codex, 2009). As part of these assessments MON 87411 must undergo an
extensive environmental assessment that requires large quantities of DvSnf7 dsRNA that was produced
by in vitro transcription (IVT). To determine if the IVT dsRNA is a suitable surrogate for the MON 87411-
produced DvSnf7 dsRNA in regulatory studies, the nucleotide sequence, secondary structure, and func-
tional activity of each were characterized and demonstrated to be comparable. This comprehensive
characterization indicates that the IVT DvSnf7 dsRNA is equivalent to the MON 87411-produced DvSnf7
dsRNA and it is a suitable surrogate for regulatory studies.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
RNA interference (RNAi) is a gene silencing mechanism trig-
gered by double-stranded RNA (dsRNA; (Fire et al., 1998)) and is a
vital part of the immune response to viruses and the regulation of
gene transcription in eukaryotes (Sharp, 2001). In addition to
regulating endogenous gene expression, dsRNA has been shown to
be an effective tool for insect control (Mao et al., 2007; Whyard
et al., 2009; Zhu et al., 2012), including western corn rootworm
(WCR, Diabrotica virgifera virgifera) and southern corn rootworm
(SCR, Diabrotica undecimpunctata howardi (Baum et al., 2007;
Bolognesi et al., 2012). One such dsRNA, DvSnf7, induces mortal-
ity in WCR (Bolognesi et al., 2012) by suppressing DvSnf7, a
component of the ESCRT-III complex (Endosomal Sorting Complex
Required for Transport-III) that is essential for biological processes
including the sorting of cell membrane receptors (Kim et al., 2011;(W. Urquhart).
Inc. This is an open access article uSweeney et al., 2006; Vaccari et al., 2009). Shortly after oral expo-
sure to DvSnf7 dsRNA, there is signiﬁcant suppression of DvSnf7
mRNA in the midgut and other tissues in the insect followed by a
reduction in DvSNF7 protein levels (Bolognesi et al., 2012). In turn,
the degradation of DvSNF7 protein leads to the accumulation of
ubiquitinated proteins, disruption of autophagy and ultimately
mortality in WCR larvae (Koci et al., 2014; Ramaseshadri et al.,
2013).
Prior to commercialization of a genetically modiﬁed crop an
extensive assessment of the inserted gene product and whole crop
is performed. The assessment of a pesticidal gene product includes
several types of studies (e.g., non-target organism testing, envi-
ronmental fate and characterization of the mechanism of action)
that require large amounts of puriﬁed product from the inserted
gene. Historically the product from the inserted gene has been a
protein that is present in amounts that are too low to feasibly
isolate in sufﬁcient quantities to conduct the full range of studies.
As such, these assessments typically use protein puriﬁed from a
bacterial expression system. Before the bacterial-expressed proteinnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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bacterial protein is a suitable surrogate (structurally and function-
ally)for the plant-produced protein from the inserted gene. A
number of comparisons including mass, sequence, immune-
reactivity, glycosylation status, and functional activity between
the bacterial-produced and plant-produced proteins are made to
demonstrate they are equivalent (Raybould et al., 2013).
Unlike other genetically modiﬁed crops that have insecticidal
activity, MON 87411 is unique in that its product from the inserted
DvSnf7 gene is a dsRNA rather than a protein. What is not unique is
the large amounts of the gene product that is needed to be pro-
duced to complete the required environmental assessments of
MON 87411's dsRNA. In order to support the environmental as-
sessments the in vitro (IVT) produced DvSnf7 dsRNA must be
demonstrated to be a suitable surrogate, in both structure and
function, to that of the plant-produced DvSnf7 dsRNA. In this paper
we describe the isolation and quantiﬁcation of DvSnf7 dsRNA in
MON 87411 and the subsequent generation and puriﬁcation of
DvSnf7 dsRNA by in vitro transcription in amounts sufﬁcient to
complete the environmental assessments regulatory studies. We
also describe the studies completed to demonstrate the structural
and functional equivalence between the IVT and MON 87411-
produced DvSnf7 dsRNA. To our knowledge, this is the ﬁrst pub-
lished demonstration of equivalence between an IVT-produced
dsRNA and plant-produced dsRNA for the purpose of an
assessment.2. Materials and methods
2.1. Transformation and DvSnf7 dsRNA expression cassette
MON 87411 was developed through Agrobacterium-mediated
transformation of immature corn embryos (Sidorov and Duncan,
2009). The R0 plants (the ﬁrst transformed generation) were
selected on medium containing glyphosate. After self pollination
and the identiﬁcation of homozygous seed, plants were subjected
to further molecular and phenotypic assessments (Data not
shown). MON 87411 was selected based on its ability to confer
resistance to WCR and its agronomic, phenotypic, and molecular
characteristics. In brief the T-DNA insert consists of two copies of a
240 bp segment of the D. virgifera gene orthologous to yeast Snf7
(sequence reported in Bolognesi et al., 2012), the repeats are
separated by a 150 bp spacer sequence and the transgene expres-
sion is driven by the CaMV 35S promoter and leader. A more
complete description of the T-DNA insert was previously described
(Armstrong et al., 2013).2.2. DvSnf7 dsRNA quantiﬁcation from MON 87411
MON 87411 leaf, root, whole plant, and grain were collected
from ﬁeld trials conducted at ﬁve sites in Argentina during the
2011e2012 growing season. At each site, four replicated plots were
planted using a randomized complete block ﬁeld design and plant
materials were collected from each replicated plot at each ﬁeld site.
Leaf, root, and whole plant were collected and placed on dry ice at
development stage vegetative 3e4 (V3eV4: Ritchie et al., 1997).
Total RNAwas extracted from a known amount of corn tissue using
the method described by Armstrong et al. (2013) and normalized to
an appropriate concentration. DvSnf7 dsRNAwas quantiﬁed using a
QuantiGene Assay method (Affymetrix Inc. 2010; Armstrong et al.,
2013). The concentration of DvSnf7 dsRNA from the assay was
converted to concentration in fresh weight (fw) tissue (ng/g fw)
based on the total RNA/tissue ratio and total RNA dilution factor.2.3. Synthesis of DvSnf7 dsRNA
The IVT dsRNA was synthesized in vitro using an E. coli T7 po-
lymerase produced by expression in BL21 (Rosetta2) competent
cells and puriﬁed using His-SELECT-HF (Sigma, St. Louis, MO). A
plasmid containing the DvSnf7 sequence was linearized with a
restriction enzyme that cut at the end of the DvSnf7 transcript and
used in an in vitro transcription reaction containing 32 mM MgCl2,
10 mM DTT, 200 mM each ATP, CTP, GTP and UTP, 10 U/ml IPP,
0.05 mg/ml T7 polymerase and 5% DMSO to produce a 968 nucle-
otide RNA. Following transcription, the RNA was heated to ~70 C
and then allowed to cool at room temperature ensuring the
inverted repeats contained within the RNA were annealed to each
other and form a hairpin loop. This dsRNA was treated with DNase
to remove any remaining plasmid and puriﬁed using phenol:-
chloroform. The pellet was resuspended in UltraPure Water (Life
Technologies, Grand Island, NY), quantiﬁed using a NanoDrop
spectrophotometer, and stored at e 80 C.
2.4. RNA isolation and mRNA enrichment
Corn leaves (V6 growth stage) from greenhouse grown plants
were collected and subsequently ground to a ﬁne powder in liquid
nitrogen. RNA was extracted using E.Z.N.A. total RNA Kit II (Omega
Bio-tek Norcross, USA). The mRNA was enriched in the samples
through the use of Omega bio-tek's Mag-Bind mRNA enrichment
kit. The following changes were made to increase mRNA capture:
(1) The bead-to-sample ratio was increased from 0.5:1 to 1:1. (2)
The supernatant from the ﬁrst mRNA capture stepwas rehybridized
in a second pass to increase the amount of mRNA captured. (3)
Washing steps were reduced from 3 times to 1. (4) The sample was
heated to 80 C for 2 min during the elution step. The mRNA was
subsequently concentrated using ethanol and sodium acetate to
precipitate the mRNA. The mRNA was resuspended in water,
quantiﬁed using a NanoDrop spectrophotometer, and stored
at 80 C.
2.5. cDNA synthesis
MON 87411 enriched mRNA was reverse transcribed using the
Omniscript Reverse Transcription kit (Qiagen, Valencia, CA). An
anchored oligo dT primer that is a random nucleotide sequence that
causes the oligo dT primer to anneal to the start of the poly (A) tail
rather than a position further downstream was used to produce
cDNA. The manufacturer's speciﬁcations were followed with the
exception of the incubation time (reaction was run for 30 min
instead of 60 min).
2.6. PCR ampliﬁcation
Two overlapping PCR products (Product A (609 base pairs) and
Product B (425 base pairs)) were generated that span the dsRNA
portion of DvSnf7 RNA sequence in MON 87411.
The PCR ampliﬁcations of Product A and B were performed on
MON 87411 DvSnf7 cDNA. The primer sequences for Product
Awere: 50-TAACAACATCAACACTCATCACTC-30 and 50-TTTGAGAA
TGAACAAAAGGACCATATCATTC-30. The primer sequences fro
Product B were: 50-ACACGCTGAACCGTCTTC-30 and 50-TAATCG
GTCGTGTGAGAGTAGTGA-30
2.7. RNA if treatment
IVT DvSNf7 dsRNA and MON 87411 RNA were digested with
RNase If (New England Biolabs, Ipswich, MA) using the manufac-
turer's suggested reaction conditions. Following the 5 min
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precipitated, and resuspended in nuclease-free water.
2.8. Northern hybridization
The probe used for northern hybridization was created with a
sequence speciﬁc to the DvSnf7 240 bp inverted repeat region.
Approximately 25 ng of probe template was labeled with [a-32P]-
dATP (~6000 Ci/mmol) using the RadPrime DNA Labeling System
(Life Technologies, Carlsbad, CA). The northern blot was hybridized
with the [a-32P]-dATP -labeled DvSnf7 probe at 55 C and washed
at the same temperature.
2.9. Functional activity analysis
SCR larvae (30 h old) were used to measure biological activity
of the IVT and MON 87411-produced DvSnf7 dsRNA. SCR eggs
were obtained from Crop Characteristics, Inc. (Farmington, MN).
The eggs were incubated at temperatures ranging from 10 C to
27 C, to achieve the desired hatch time. Each bioassay replicate
consisted of a series of seven dilutions yielding a concentration
series with a two-fold separation factor ranging from 0.78 to 50 ng
DvSnf7 RNA/ml diet for IVT and MON 87411-produced DvSnf7
dsRNA along with three control (water) replicates. This concen-
tration series in diet was chosen because it brackets the previously
determined 12-day SCR LC50 value (Data not shown). The IVT-
produced DvSnf7 dsRNA was run in parallel as a positive control.
Each bioassay was replicated three times on separate days, and
each with a separate batch of SCR larvae. Concentration levels for
the IVT and MON 87411-produced DvSnf7 dsRNA were selected to
fully characterize the concentrationeeffect relationship and to
provide an accurate estimate of the LC50 value. The total RNA
levels were not consistent between the IVT and plant produced
samples. However, in bioassays where the conventional corn
mRNA levels exceeded the levels used in bioassays with MON
87411-produced material, no effects on SCR mortality were
observed (data not shown).
DvSnf7 RNA solutions were prepared by diluting the IVT and
MON 87411-produced DvSnf7 dsRNA with Ultrapure™ distilled
water and incorporating the dilution into a SCR diet (Bio-Serv,
Frenchtown, NJ). The diet mixture (0.25 ml/well) was then
dispensed into a 48-well plate (# 3078, Becton Dickson Labware,
Franklin Lakes, NJ) and one insect larva was placed on each diet-
ﬁlled well using a ﬁne paintbrush. The target number of insects
per treatment was 30. The infested wells were covered with heat-
sealing mylar and each well was punctured with a #1 or #2 insect
pin to allow for ventilation. The insects were allowed to feed for a
period of 12-days in an environmental chamber programmed at
27 C, 70% relative humidity and in complete darkness. The number
of insects infested and the number of survivors were recorded at
the end of the 12-day bioassay.
2.10. Estimation of the LC50 and the generation of the bioassay
prediction interval
For each of the bioassays, LC50 values were estimated separately
for DvSnf7 dsRNA isolated from MON 87411 and the IVT-produced
DvSnf7 dsRNA using probit analysis under PROC Probit in (SAS 9.3)
with correction for the level of natural mortality observed in the
water control (Finney, 1971). Bioanalytical methods typically have
high variability and LC50 values are not biological constants;
therefore it is important to deﬁne the acceptance limits to interpret
bioanalytical data developed to assess equivalence. In this study,
the acceptance limits for functional equivalence have been based
on a prediction interval (PI), which is a well established techniquefor setting acceptance criteria (Hahn and Meeker, 1991). A two-
sided PI for the next two averages of three independent bioassays
was estimated from the historic data for IVT-produced DvSnf7
dsRNA prior to initiating the analysis with DvSnf7 dsRNA isolated
from MON 87411. Twenty-four log transformed LC50 values from
independent assays (Supplementary Table 1) were used to
construct the PI. A log transformation of the LC50 values was used in
the PI calculation to meet the assumption of normality (Hahn and
Meeker, 1991) and because toxicity data is typically log normally
distributed (Burmaster and Hull, 1997; Solomon and Takacs, 2002).
Producing an average value from three independent bioassays
carried out on different days that is brought into subsequent ana-
lyses has been a recommended approach (U.S. EPA, 2009a). A
sample size of eight is considered to be sufﬁcient to derive a PI (U.S.
EPA, 2009b). Unlike conﬁdence intervals, the width of a prediction
interval does not continue to decrease as the sample size increases
(Hahn andMeeker,1991). Thus, the inclusion of additional data into
the prediction interval calculation would not substantially change
the width of each acceptance criterion.
The PI was calculated using the following equation:
PI ¼Mean LC50Ht1f=2k0n1,
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
m
þ 1
n
s
,S
where n represents the number of LC50 values (n¼ 24 in this study),
k represents the number of future mean LC50 values (k ¼ 2 in this
study), m represents the number of future bioassays in each mean
(m ¼ 3 in this study), and S is the standard deviation. The magni-
tude of S is largely determined by inter-assay variation and is an
inﬂuential factor impacting the size of the PI. The above equation is
a combination of the formulas for PIs for the mean of m future
observations and PIs to contain k future observations (Hahn and
Meeker, 1991). The interval calculated was a 95%. The estimated
PI was back-transformed to create the PI on an arithmetic scale that
was used as the acceptance criterion for functional equivalence. To
make a conclusion of functional equivalence, the LC50 values from
three replicate assays of plant-produced and IVT-produced DvSnf7
dsRNA are ﬁrst log transformed. The mean value can then be
calculated on log transformed LC50 values. The back-transformed
means for plant-produced and IVT-produced DvSnf7 dsRNA must
be contained within the prediction interval. Containment of the
plant-produced DvSnf7 dsRNA in the prediction interval is used to
demonstrate equivalence and containment of the IVT-produced
DvSnf7 dsRNA in the prediction interval is used as a positive con-
trol of the assay. Assays for the plant-produced and IVT produced
DvSnf7 dsRNA were conducted in parallel for the assessment of
equivalence and were assumed to be independent.3. Results
MON 87411 is a biotechnology-derived corn variety that was
generated by Agrobacterium-mediated transformation of immature
corn embryo (Sidorov and Duncan, 2009) and confers protection
against corn rootworm (CRW) (Diabrotica spp.) and tolerance to the
herbicide glyphosate (data not shown). MON 87411 carries a single
copy of the transforming T-DNA insert that contains a constitutively
expressed transgene that includes two copies of a 240 bp segment
from D. virgifera (DvSnf7) in inverted repeat orientation (data not
shown). These two repeats are separated by a 150 bp spacer
sequence and align completely in reverse complement fashion.
In order to conduct studies required by some regulatory
agencies for MON 87411, gram amounts of DvSnf7 dsRNA are
needed. To determine the expression level of DvSnf7 dsRNA in
MON 87411, expression analyses were conducted to determine the
1000
1              2           3              4            5            6
IVT MON 87411 
nt
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DvSnf7 dsRNA expression levels in MON 87411 were assessed in
four tissue types from ﬁve ﬁeld sites (Table 1). Leaf, root, whole
plant, and grain were selected because they are representative
tissue types of a corn plant and provide an estimation of the DvSnf7
dsRNA levels in MON 87411. The individual DvSnf7 dsRNA levels in
MON 87411 across all samples analyzed from all sites ranged from
lower than the limit of quantitation (<LOQ) to 23.1 ng/g fw. The
sample means, SDs, and ranges (minimum and maximum values)
were calculated for each tissue type across all ﬁve sites (Table 1).
The mean DvSnf7 dsRNA level for each tissue type was highest in
leaf at 12.6 ng/g fw and lowest in grain at 0.091 ng/g fw.
Although the expression level of DvSnf7 dsRNA is several
hundred-fold higher in leaf than grain, the levels are still too low to
extract enough DvSnf7 dsRNA from MON 87411 to complete the
studies needed for regulatory approval. For example, to extract and
purify the several grams of DvSnf7 RNA needed for required reg-
ulatory studies it would take several hundred thousand kgs of corn
leaf tissue. This is not feasible, therefore in order to produce enough
RNA, in vitro transcribed DvSnf7 dsRNA (IVT DvSnf7 dsRNA) was
produced. Gram amounts of DvSnf7 were produced using a E. coli
T7 polymerase and the followingmolecular and functional analyses
were performed to demonstrate equivalence between IVTandMON
87411-produced DvSnf7 dsRNA.
3.1. MON 87411 and the IVT produced DvSnf7 dsRNA have identical
nucleotide sequences
In order to demonstrate molecular equivalence between MON
87411-produced DvSnf7 dsRNA and IVT DvSNf7 dsRNA, the
sequence of both dsRNAs were determined. The dsRNAs were
reverse transcribed into cDNA and ampliﬁed by PCR. The ampliﬁed
DvSnf7 cDNAs were sequenced to obtain the transcript sequence
which contains the predicted transcription start and poly-
adenylation sites, and most importantly, the 240 nucleotide
double-stranded functional region (inverted repeat) of the dsRNA
(Bolognesi et al., 2012; Coruzzi et al., 1984). The consensus
sequence of the MON 87411-produced DvSnf7 cDNAwas aligned to
the sequence of the IVT DvSnf7 cDNA. This analysis demonstrated
that the sequenced regions are identical in the IVT and MON 87411-
produced DvSnf7 dsRNA. (data not shown). Although the sequences
of the functional regions are identical, the activity of the DvSnf7
dsRNAs is also dependent on the secondary structure and the
production of a double-stranded region.
3.2. MON 87411 and the IVT produced DvSnf7 dsRNA both produce
double-stranded regions
To determine if the identical dsRNA sequences of the IVT andTable 1
DvSnf7 dsRNA levels in MON 87411 tissues.
Tissue type Meana (SD)
Range (ng/g fw)
LOD/LOQ
(ng/g fw)
Leaf 12.6 (2.11) 0.129/0.566
8.53e16.6
Root 3.15 (1.79) 0.029/0.128
1.74e8.00
Whole plant 10.5 (4.25) 0.078/0.345
6.78e23.1
Grain 0.091 (0.028) 0.008/0.036
0.049e0.153
a The sample means, SDs, and ranges (minimum and maximum values) were
calculated for each tissue type across all 5 sites (n ¼ 20 for leaf, root, and whole
plant; n ¼ 18 for grain due to expressions from 2 grain samples < LOQ).plant-produced DvSnf7 produce equivalent secondary structure,
mRNA enriched from MON 87411 (which contains MON 87411-
produced DvSnf7 dsRNA) and IVT DvSNf7 dsRNA were digested
by RNase If. RNase If preferentially digests single stranded RNA
leaving dsRNA regions intact. Each RNase If digested sample was
loaded in triplicate and subjected to northern blot analyses. The
northern blot was hybridized with a probe speciﬁc to the 240
nucleotide dsRNA region of DvSnf7 in order to make a comparison
of the dsRNA regions of the IVT and MON 87411-produced DvSnf7
dsRNA. Both IVT andMON 87411-produced DvSnf7 dsRNA contain a
~240 nucleotide dsRNA product (Fig. 1). This is the size of the
double-stranded functionally active region of DvSnf7 (Bolognesi
et al., 2012). Therefore, the IVT DvSnf7 dsRNA is forming an
equivalent size of double-stranded region to that of the MON
87411-produced DvSnf7 dsRNA indicating that the functional ac-
tivity of the two DvSnf7 dsRNAs is likely conserved.3.3. MON 87411 and the IVT-Produced DvSnf7 dsRNA have
equivalent functional activity
MON 87411-produced DvSnf7 dsRNA demonstrated concentra-
tion dependent mortality on SCR (Fig. 2). LC50 values for the three
bioassays with the plant-produced DvSnf7 dsRNA had similar
values (5.73, 6.90, and 6.98 ng DvSnf7/ml diet) with a geometric
mean value of 6.51 ng DvSnf7/ml diet (Table 2). The geometric
mean LC50 value for MON 87411-produced DvSnf7 dsRNA falls
within the PI of 3.82e20.60 ng DvSnf7/ml diet developed with IVT
DvSnf7 dsRNA indicating comparable functional activity between
the dsRNA from both sources. The IVT-produced DvSnf7 dsRNA that
was run as a positive control along with the plant-produced ma-
terial had an indistinguishable shape and location of the concen-
tration response curve indicating almost the same potency and
efﬁcacy (Fig. 2). LC50 values for the three diet bioassays with the
IVT-produced DvSnf7 dsRNA also had similar values (5.92, 7.04 and,
7.10 ng DvSnf7/ml diet) with a geometric mean value of 6.66 ng
DvSnf7/ml diet. The geometric mean LC50 value for IVT produced
DvSnf7 dsRNA that was run in parallel also falls within the PI of
3.82e20.60 ng DvSnf7/ml diet developed with IVT DvSnf7 dsRNA
demonstrating the validity of the of the PI to assess the activity of
DvSnf7 dsRNA.800
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Fig. 1. Northern blot analysis to conﬁrm the equivalence between the double-stranded
regions in MON 87411 and IVT-produced DvSnf7 dsRNAs. IVT DvSnf7 dsRNA and MON
87411-produced DvSnf7 dsRNA were digested with RNase If. The remaining dsRNAs
were separated on a denaturing gel and transferred to a membrane. The northern blot
was hybridized with a 32P-labled, DvSnf7 probe speciﬁc to the 240 nucleotide inverted
repeat region. Lanes 1e3 contain ~7 ng of RNase If digested IVT DvSNf7 dsRNA and
lanes 4e6 contain ~13 mg of RNase If digested MON 87411 mRNA (contains DvSnf7
dsRNA).
25
50
75
100
IVT produced DvSnf7 RNA
MON 87411 produced DvSnf7 RNA
DvSnf7 Concentration (ng/ml diet)
0
0 12.5 25 506.25
P
er
ce
nt
 In
se
ct
 S
ur
vi
va
l
Fig. 2. Southern corn rootworm (SCR) concentrationeresponse relationships for
DvSnf7 from in vitro (IVT) and MON 87411 produced dsRNA in 12-day SCR diet
incorporation bioassays. Each point represents the mean of three independent bio-
assays along with the standard error of the mean.
Table 2
Functional Activity of plant-produced (MON 87411) and in vitro (IVT)-produced DvSnf7 dsRNA: Geometric mean (Geomean) of estimated LC50 values (n¼ 3) and the prediction
interval (PI) based on LC50 values from 24 previous bioassays with IVT produced DvSnf7 dsRNA.
MON 87411-produced DvSnf7 dsRNA Geomean LC50
(ng DvSnf7/ml diet)
IVT-produced DvSnf7 dsRNA Geomean LC50
(ng DvSnf7/ml diet)
Acceptance limits
Based on PI
(ng DvSnf7/ml diet)
6.51 6.66 3.82e20.60
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Internationally accepted guidelines for the assessment of
biotechnology-derived crop products have been developed to ensure
that these plants are as safe for food, feed, and environmental release
as their conventional (non-modiﬁed) counterparts (Codex, 2009).
These guidelines address the safety of both the intended changes and
also any unintended changes from introducing the trait into the crop.
The intended change in a new biotechnology-derived product is the
desired phenotype and, typically, the protein expressed by the
transgene. However, in the case of MON 87411 one of the transgene
expression products is an mRNA that produces DvSnf7 dsRNA.
Therefore, to complete regulatory requirements for MON 87411,
several grams of DvSnf7 dsRNA were needed, however this RNA is
expressed at relatively low levels in MON 87411 (Table 1) meaning it
is not feasible to purify sufﬁcient amounts from the plant. This is a
common consideration for protein expression products as well. In
fact, for safety testing of an transgene encoded inserted protein it is
common to express and extract the protein from E. coli (Gao et al.,
2006; Herouet et al., 2005; Xu et al., 2009). Similarly in order to
produce enough dsRNA for regulatory testing, in vitro transcription
was used to product large amounts of DvSnf7 dsRNA. Prior to using
this material in regulatory studies, it is critical to demonstrate that
the IVT-produced DvSnf7 dsRNA is a suitable surrogate for the MON
87411-produced DvSnf7 dsRNA.
A weight of evidence approach is important for establishing the
equivalence between the plant-produced material and the pro-
posed test surrogate (Raybould et al., 2013). For proteins the weight
of evidence approach includes comparisons of apparent molecular
mass, amino acid sequence, immune-reactivity, glycosylation sta-
tus, and functional activity between the plant and E. coli produced
proteins (Raybould et al., 2013). To establish the equivalence ofplant and IVT-produced dsRNA a similar weight of evidence strat-
egy was used that included an assessment of nucleotide sequence,
RNA structure, and functional activity.
Nucleotide sequencing demonstrated that the IVT DvSNf7
dsRNA sequence including the inverted repeat region is identical to
that of the MON 87411-produced DvSnf7 dsRNA. In addition to
identical nucleotide sequences, the IVT and MON 87411-produced
DvSnf7 dsRNA both form similar sized dsRNA regions (Fig. 1).
These two molecular analyses demonstrate that the required
sequence (Baum et al., 2007) and size (Bolognesi et al., 2012) of
dsRNA are present in both the IVT and MON 87411-produced
DvSnf7 dsRNAs. Although the sequence and double-stranded por-
tions are the same, the in vitro transcription process does not add a
50 methyl cap or a 30 polyadenylation to the IVT DvSnf7 dsRNA.
Although it is clear that plant produced mRNAs, including DvSnf7
produced in MON 87411, likely contain these molecule features, it is
not clear whether they are important for DvSnf7 function.
Post transcriptional modiﬁcations, including methyl caps and
polyadenylation tails have a range of functions (Lewis et al., 1995). It
has been suggested that these modiﬁcations increase the stability
of the molecule by two to four fold, however their primary function
is to increase the translation efﬁciency (Gallie, 1991). Since theDvSnf7 dsRNA is not translated, the absence of a 50 cap and a 30
polyadenylation on the IVT DvSnf7 dsRNA should not diminish its
ability to act as a surrogate for MON 87411-produced DvSnf7
dsRNA. In order to test this hypothesis and demonstrate that the
IVT-produced material could be used as a surrogate in regulatory
studies, a comparison of functional activity between the IVT and
MON 87411-produced DvSnf7 dsRNA was performed.
The comparison of functional activity between MON 87411-
produced DvSnf7 dsRNA and IVT-produced DvSnf7 dsRNA was
performed by comparing a 12-day LC50 value with a PI developed
from previously generated 12-day LC50 values for IVT-produced
DvSnf7 dsRNA. The LC50 value for MON 87411-produced DvSnf7
dsRNA falls within the PI developed with IVT DvSnf7 dsRNA indi-
cating comparable functional activity between the dsRNA from
both sources. The mean LC50 value for IVT-produced DvSnf7 dsRNA,
that was run in parallel as a positive control with the MON 87411-
produced DvSnf7 dsRNA, also fell within the PI for IVT DvSnf7
dsRNA demonstrating the validity of the of the PI to assess the
activity of DvSnf7 dsRNA.
Biological responses such as LC50 values are not constants; they
are variable over time between batches of insects because of day-
to-day variation in physiology and sensitivity to toxic substances
(Casarett et al., 2003). For this reason the use of a prediction interval
(PI) is more appropriate to determine if two materials have com-
parable potency in a bioassay. A PI takes into account the inter assay
variation by repeating measurements on the same sample and
provides a reliable estimate of the interval which will encompass a
future measurement(s) (Hahn and Meeker. 1991). PIs have a long
standing history of use in the pharmaceutical industry and medical
ﬁeld to set acceptance criteria for analytical methods used to assess
drug quality, to test for equivalence between two sources of a drug,
to test for appropriate drug response, and to set reference ranges
W. Urquhart et al. / Regulatory Toxicology and Pharmacology 73 (2015) 607e612612for normal and diseased states (Bangert et al., 2008). A prediction
interval can be determined based on a set of existing observations,
and thus, for the equivalence assessment, is appropriate for assays
where a body of data is available for the reference dsRNA prior to
the equivalence assessment. The primary advantage of using a
prediction interval method is that the it takes into consideration
the inherent variability of the test system. For these reasons, a PI
was calculated using data from previously SCR bioassays completed
with IVT-produced DvSnf7 dsRNA (Supplementary Table 1). The
mean LC50 value estimated for the MON 87411-produced DvSnf7
dsRNA and IVT DvSNf7 dsRNA ﬁt within the prediction interval
indicating the MON 87411 and IVT-produced DvSnf7 dsRNAs have
equivalent functional activity (Table 2).
Taken together the weight of evidence from nucleotide
sequencing, northern blot analysis of the dsRNA region, and func-
tional activity of the MON 87411 and IVT-produced DvSnf7 dsRNA
indicates that these dsRNAs are equivalent. These data indicate that
the IVT-produced DvSnf7 dsRNA is structurally and functionally
equivalent and can act as a surrogate material in regulatory studies
assess the environmental safety DvSnf7 dsRNA produced by MON
8741. Furthermore, these methods provide a framework by which
IVT dsRNAs can be evaluated to demonstrate equivalence to plant-
produced dsRNAs.
Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.yrtph.2015.09.004.
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